Airway diseases
Interstitial lung diseases
Oral presentation
Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Methods :
Pulmonary function testing, General respiratory patient care, Cell and molecular biology
09:30
Introduction
OA4233
09:35
Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD): an international research prioritisation
H. Bintalib(London, United Kingdom)
COI
09:40
Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
F. Lestelle(Lyon, France)
COI
09:45
Idiopathic chronic obliterative bronchiolitis: a multicentric retrospective cohort
M. Nasser(Bron, France)
COI
09:50
Specifying pediatric pulmonary hemorrhage: Suggestion of a diagnostic algorithm as guide to disease subcategories
K. Knoflach(München, Germany)
COI
09:55
Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data
T. Maher(Los Angeles, United States)
COI
10:00
Prevalence of lymphangioleiomyomatosis in an Irish population and biomarker utility
E. Lynn(Blackrock (Co. Dublin), Ireland)
COI
10:05
Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
L. Jehn(Essen, Germany)
COI
10:10
A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
C. Lee(Yongin, Republic of Korea)
COI
10:15
Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis
L. Pandolfi(Pavia, Italy)
COI
10:20
Late Breaking Abstract - Role of matrix metalloproteinase-2 and -9 in experimental lung fibrosis in mice
T. Röpke(Hannover, Germany)
COI
. . .
